Gilead Sciences | Marknadsvärde



Market Capitalization Ändra Datum
AbbVie USD 348.39B 22.24B 2025-05
Agios Pharmaceuticals USD 1.76B 69M 2025-05
ALKERMES USD 4.95B 495M 2025-05
Alnylam Pharmaceuticals USD 33.57B 1.55B 2025-05
Amgen USD 149.44B 18.07B 2025-05
Biogen USD 17.88B 2.15B 2025-05
BioMarin Pharmaceutical USD 11.72B 1.84B 2025-05
Bristol-Myers Squibb USD 101.45B 22.65B 2025-05
Eli Lilly USD 782.87B 41.21B 2025-05
Gilead Sciences USD 129.47B 10.21B 2025-05
GlaxoSmithKline GBP 60.04B 311.52M 2025-05
Glaxosmithkline USD 69.83B 14.22B 2024-12
Incyte USD 13.94B 2.22B 2025-05
J&J USD 374.87B 24.78B 2025-05
Merck USD 212.34B 13.54B 2025-05
Moderna USD 10.54B 425M 2025-05
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 137.09B 6.62B 2025-05
PTC Therapeutics USD 3.51B 653M 2024-12
Regeneron Pharmaceuticals USD 66.6B 2.74B 2025-05
Sanofi EUR 122.48B 3.37B 2025-05
Sarepta Therapeutics USD 11.78B 128M 2024-12
United Therapeutics USD 13.91B 17M 2025-05
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Gilead Sciences Marknadsvärde - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.